Self-Motivation
David Goggins
Former Navy Seal
Career Development
Bryan Cranston
Actor
Critical Thinking
Liv Boeree
International Poker Champion
Emotional Intelligence
Amaryllis Fox
Former CIA Clandestine Operative
Management
Chris Hadfield
Retired Canadian Astronaut & Author
Learn
from the world's big
thinkers
Start Learning

How do you explain American Muslim antipathy toward Israel?

Question: How do you explain American Muslim antipathy toward Israel

Barrett: It is a question of partisanship. It’s a question of real estate. It’s a question of a historical clash over a . . . you know a place in a . . . in a much disputed, much beloved, tiny slice of existence in the Middle East. You know I would not say all Muslims; but I would say it’s pretty safe to say most Muslims, but particularly Muslims who have their roots in the Arab, world view Israel as an illegitimate entity. They think it was wrong to set the country up. They think Palestinians were unjustly chased from their land, and that Israel is an oppressor state. Now most of the more sophisticated Arab Americans understand that Israel is not going away, and that what needs to happen is some kind of compromise. And many of them are entirely willing to talk about such things and so forth. But they may be wary of doing that in public. They may be wary of doing that with Jews. And what they are very resentful of – and here, whether you agree with them on the merits or not – their procedural complaint is very legitimate. And their procedural complaint is it is very difficult in this country to voice hostility toward Israel; to voice support for the Palestinians; to voice strong criticism of the nearly unanimous bipartisan support for almost anything the Israeli government does. So whether I, Paul Barrett, am a supporter of the Israeli government or not, I can entirely sympathize with the protests that I, American citizen of Arab decent – a Muslim from anywhere in the world feel I should be able to stand up and criticize Israel and what it does. That seems legitimate to me. Recorded on: 12/4/07

It's a question of real estate, says Barrett.

How often do vaccine trials hit paydirt?

Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.

Pedro Vilela/Getty Images
Surprising Science

Vaccines are more likely to get through clinical trials than any other type of drug — but have been given relatively little pharmaceutical industry support during the last two decades, according to a new study by MIT scholars.

Keep reading Show less

Leadership, diversity and personal finance in the COVID-19 era

Sallie Krawcheck and Bob Kulhan will be talking money, jobs, and how the pandemic will disproportionally affect women's finances.

Hints of the 4th dimension have been detected by physicists

What would it be like to experience the 4th dimension?

Two different experiments show hints of a 4th spatial dimension. Credit: Zilberberg Group / ETH Zürich
Technology & Innovation

Physicists have understood at least theoretically, that there may be higher dimensions, besides our normal three. The first clue came in 1905 when Einstein developed his theory of special relativity. Of course, by dimensions we’re talking about length, width, and height. Generally speaking, when we talk about a fourth dimension, it’s considered space-time. But here, physicists mean a spatial dimension beyond the normal three, not a parallel universe, as such dimensions are mistaken for in popular sci-fi shows.

Keep reading Show less

Consumer advocacy groups are mostly funded by Big Pharma, according to new research

An article in Journal of Bioethical Inquiry raises questions about the goal of these advocacy groups.

Image by Jukka Niittymaa / Pixabay
Politics & Current Affairs
  • Two-thirds of American consumer advocacy groups are funded by pharmaceutical companies.
  • The authors of an article in Journal of Bioethical Inquiry say this compromises their advocacy.
  • Groups like the National Alliance on Mental Illness act more like lobbyists than patient advocates.

Keep reading Show less
Quantcast